Predictive Assay for Decision Making in Adjuvant Therapy
Public ClinicalTrials.gov record NCT05032352. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Predictive Assay for Decision Making in Adjuvant Therapy (PADMA)
Study identification
- NCT ID
- NCT05032352
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Insight Molecular Diagnostics
- Industry
- Enrollment
- 55 participants
Conditions and interventions
Conditions
Interventions
- Adjuvant Drug
- Observation Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 27, 2022
- Primary completion
- Oct 27, 2022
- Completion
- Oct 27, 2022
- Last update posted
- Nov 13, 2022
2022
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| George Washington Medical Faculty Associates | Washington D.C. | District of Columbia | 20037 | — |
| Jupiter Medical Center | Jupiter | Florida | 33458 | — |
| Piedmont Cancer Center | Atlanta | Georgia | 30309 | — |
| Northshore University Healthsystem | Evanston | Illinois | 60201 | — |
| The University of Kansas Hospital | Kansas City | Kansas | 66160 | — |
| Our Lady of the Lake Regional Medical Center | Baton Rouge | Louisiana | 70808 | — |
| Penn Presbyterian Medical Center | Philadelphia | Pennsylvania | 19104 | — |
| Texas Oncology-San Antonio Medical Center | San Antonio | Texas | 78240 | — |
| Methodist Healthcare | San Antonio | Texas | 78249 | — |
| Texas Oncology-Wichita Falls Cancer Center | Wichita Falls | Texas | 76310 | — |
| Virginia Cancer Specialists | Fairfax | Virginia | 22031 | — |
| Mary Washington Hospital | Fredericksburg | Virginia | 22401 | — |
| Providence Regional Medical Center Everett | Everett | Washington | 98201 | — |
| Peace Health | Vancouver | Washington | 98683 | — |
| West Virginia University Medicine | Morgantown | West Virginia | 26506 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05032352, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2022 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05032352 live on ClinicalTrials.gov.